Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECCLIPSE-STEMI: IV Lysine Acetylsalicylate vs Oral Aspirin
NCT02929888Phase 3Unknown
- Sponsor
- Fundación Interhospitalaria para la Investigación Cardiovascular
- Start
- Oct 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lysine acetylsalicylate in ST-segment elevation myocardial infarction (STEMI), sponsored by Fundación Interhospitalaria para la Investigación Cardiovascular. Status: unknown.
02
Drugs
lysine acetylsalicylate
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02929888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929888.